noscript

News and Announcements

Proteomics March Update: PromarkerD Progress, Indian Biotech Market Expansion & Solid Quarter Results

  • Published April 26, 2016 11:48AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

26th April 2016, ASX Announcement

Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) (the Company, PILL)  is pleased to provide the following update on its business activities for the three month period to 31 March 2016.

Highlights 

  • PromarkerD progress: 500 patient follow-up validation study underway to further validate PromarkerD’s initial ground-breaking results.
  • IVD test kit for PromarkerD: Assessing development program to produce a clinical pathology In Vitro Diagnostic (IVD) test kit for PromarkerD.
  • Therapeutic Drug Discovery Program: to discover new analgesic and antibiotics drug compounds.
  • Analytical Services operations: Solid quarter-on-quarter results.
  • Business Development: Company expands operations in massive Indian biotech market.

The March quarter delivered another period of sound performance for PILL. During the quarter, it embarked on a number of programs utilising its proprietary, disruptive technology platform. This included a development program, to produce a standard clinical pathology In Vitro Diagnostic (IVD) test kit for PromarkerD.

To view the full article, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now